Healthcare
Live Price
Offline$97.09
+0.00% today
Window Change
-61.16%
Window
Jun 23, 2025 โ Apr 29, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 197 bars ยท Jun 23, 2025 โ Apr 29, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
BerGenBio ASA (BRRGF) is a Healthcare stock with a market cap of $9.49B. The stock last traded around $97.09 and down 61.2% across the available one-year price window (Jun 23, 2025 โ Apr 29, 2026). Baseline metrics include revenue growth of +139.5%, EPS growth of +41.6%, a dividend yield of 0.0%. What stands out right now is revenue +139.5%, EPS +41.6%, free cash flow +31.9% with operating margin -2133.2% and ROIC -172.1%. Valuation already assumes a fairly strong business story at price/sales 39.9. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines BRRGF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+139.5% vs +7.6% peer median
Operating Margin
Below sector median
-2133.2% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 19, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +139.5% and EPS at +41.6%, with operating margin around -2133.2%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Feb 19, 2026 | โ | +0.0% | +0.0% | +0.0% |
2025 Nov 19, 2025 | โ | +0.0% | +0.0% | +0.0% |
2025 Aug 19, 2025 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
BRRGF
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
BRRGF Max Drawdown
-99.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for BRRGF and SPY.
Company Overview
BerGenBio ASA
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.